Review to consider ‘cancer drugs fund’ for innovative medicines

Pills and tablets

The government’s accelerated access review will look at whether the principle of the cancer drugs fund could be extended to non-cancer treatments, its chair has said.

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here